Experimentally, they also showed that knock-down of TGFBR2 in CAFs resulted in increased cell growth, proliferation and clonogenic survival of breast cancer cells and suggest that regulation of tumour-stromal cross-talk through fibroblastic TGF-β pathway may depend on fibroblast phenotype. This evidence concerns the gene TGFBR2 and neoplasm.